Jan 31, Toronto, Ont. - Theralase Technologies Inc. is pleased to announce that it has been granted notified body approval to place the CE mark on its TLC-1000 series of products, clearing the way for sale of its laser products throughout all 30 member states of the European Union (EU).
CE approval is a mandatory approval stage in the sale of products to European Union (EU) countries. It serves as a declaration that the product meets EU consumer safety, health and environmental requirements.
“Achieving CE approval allows Theralase another opportunity to expand the sale of our medical lasers internationally", stated Roger Dumoulin-White, President and CEO of Theralase Technologies Inc. "By possessing CE approval, in addition to our Health Canada, FDA and certain Latin American and Asian approvals, we are now able to sell our medical lasers to over 63 per cent of the worldmarket (as measured by GDP). This presents a great opportunity for Theralase to expand our revenue generation capability beyond our present markets."
For more information visit the corporate or regulatorywebsite at
www.theralase.com or www.sedar.com
Theralase approved for Europe
PODCAST Episode 1: Can Massage Therapists improve relations with the insurance industry?The relationship between massage therapists and insurance companies can be…
PODCAST: On The Table – Current and critical information for massage therapists in practiceWelcome to Massage Therapy Canada's podcast!
Muscle memory discovery ends 'use it or lose it' dogmaThe old adage "use it or lose it" tells us:…
Am I too sick to work?Newswise — You're sniffling, sneezing, and your nose is running…
Calgary Wellness Expo
March 8-9, 2019
Canadian Pain Society 40th Annual Scientific Meeting
April 2-5, 2019